According to FutureWise analysis the market for Sulphonamides in 2023 is US$ 0.11 billion, and is expected to reach US$ 0.16 billion by 2031 at a CAGR of 4.70%.
Sulfonamides, also known as sulfa drugs or sulpha drugs, are organic sulfur compounds that contain the radical SO2NH2 (the amide of sulfonic acid). These are the first anti-microbial drugs developed for treating bacterial infections in humans and animals. The sulfonamides interfere with the synthesis of folic acid in bacterial cells by inhibiting the enzyme dihydropteroate synthetase, which competes with para amino benzoic acid (PABA). Folic acid is a precursor to ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) in bacterial cells. Since sulfonamides limit bacterial growth, they are considered bacteriostatic agents. A few sulfonamides are very water-soluble such as sulfisoxazole (sulfafurazole) and sulfasomidine, which are rapidly excreted through the urinary tract (more than 90% in 24 hours) primarily in an unchanged drug form; because of this pharmacokinetic property, these sulfonamides are primarily used to treat urinary tract infections (UTI's). Moreover, some sulfonamide derivatives, such as sulfaguanidine, are insoluble in nature, so they cannot be absorbed from the gastro intestinal tract (less than 5%), so they are used to treat ulcerative colitis. Several people are allergic to sulfa drugs, so sulfonamides are prescribed with caution. Among the potential side effects of sulfonamides are urinary tract disorders, haemopoietic disorders, hypersensitivity reactions, and porphyria.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Sulphonamides Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Sulphonamides Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.